Preparation method of nicardipine hydrochloride

By using mixed solvent purification of acetone, tetrahydrofuran and acetonitrile and 2-naphthalenesulfonyl chloride to replace traditional compounds, the problems of nicardipine hydrochloride content control and high cost are solved, and the industrial production of high-content products is achieved, which meets the requirements of the pharmacopoeia and simplifies the Craft.

CN118930478AActive Publication Date: 2024-11-12WISDOM PHARMACEUTICAL CO LTD +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410986457.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-12
Estimated Expiration
2044-07-23

AI Technical Summary

Technical Problem

In the existing nicardipin hydrochloride synthesis process, the nicardipin hydrochloride content is difficult to control and meet the requirements of the pharmacopoeia. The solvents and condensants used are costly and cumbersome, which is not conducive to industrial production.

Method used

Refining is carried out using specific mixed solvents including acetone, tetrahydrofuran and acetonitrile, and 2-naphthalenesulfonyl chloride is used instead of traditional methylsulfonyl chloride and p-methylbenzenesulfonyl chloride to avoid EDCI condensation agents, simplify the process flow, and reduce production costs.

Benefits of technology

The content of nicadipine hydrochloride reaches 99.9-101.0%, which meets the requirements of the pharmacopoeia, avoids benzene solvent residues and potential genotoxic impurities, reduces production costs, simplifies the process flow, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930478A_ABST
    Figure CN118930478A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of nicardipine hydrochloride, which comprises the following steps: taking 1, 4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl) pyridine-3, 5-dicarboxylic acid monomethyl ester and 2-chloroethanol as starting materials to obtain a compound 3; then reacting and esterifying with 2-naphthalenesulfonyl chloride to obtain a compound 5; reacting with N-methylbenzylamine for substitution, and adding hydrochloric acid for salifying to obtain a crude product compound 7; and finally refining to obtain the nicardipine hydrochloride. According to the invention, the use of EDCI and other expensive condensing agents for condensation in the preparation process is avoided, and the production cost is reduced; and specific mixed solvents acetone, tetrahydrofuran and acetonitrile are adopted in the refining process, and anhydrous magnesium sulfate is not needed for drying, so that the preparation process is simplified, and industrial production is facilitated. The content of the prepared nicardipine hydrochloride is 99.98-100.10%, a benzene solvent is not detected, and the nicardipine hydrochloride does not contain potential genotoxic impurities and meets the requirements of pharmacopeia.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medicines, and particularly relates to a preparation method of nicardipine hydrochloride. Background Art

[0002] Nicardipine Hydrochloride is a potent calcium antagonist of the dihydropyridine class that can inhibit calcium influx and selectively inhibit phosphodiesterase in the brain and coronary arteries to increase intracellular cyclic adenosine monophosphate (CAMP) levels, thereby relaxing vascular smooth muscle and producing a significant vasodilation effect, thereby achieving rapid blood pressure reduction and significantly increasing cerebral blood flow. It has significant effects in treating hypertension, cerebrovascular disease, cerebral thrombosis or sequelae of cerebral hemorrhage and arteriosclerosis, and also has a certain effect on coronary heart disease and angina pectoris. Nicardipine Hydrochloride has the advantages of high efficiency, wide indications and few side effects.

[0003] Nicardipine hydrochloride, whose chemical name is 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid, 3-[β-(N-benzyl-N-methyl)amino]ethyl ester-5-methyl ester hydrochloride, has a molecular formula of C 26 H 29 N3O6·HCl, the chemical structure is as follows:

[0004]

[0005] At present, in the synthesis process of nicardipine hydrochloride, N-methylbenzylamine is generally used as the starting material. The industrial production of N-methylbenzylamine is obtained by reacting benzyl chloride with monomethylamine in a benzene solvent. Benzene is a Class 1 solvent, and the PDE value (PDE refers to the maximum daily average dose of a certain organic solvent that is allowed to be ingested without toxicity) is 0.0002%. The risk of pharmaceutical residues is high, and the residue of monomethylamine often introduces impurities without ultraviolet absorption. The content of nicardipine hydrochloride is difficult to control and cannot meet the requirements of the pharmacopoeia (99.0-101.0%). Therefore, how to obtain a high content of nicardipine hydrochloride is one of the difficulties in research and development. At the same time, in the synthesis process of the existing nicardipine hydrochloride side chain, condensation reagents such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDCI) are also used, or anhydrous magnesium sulfate is used for drying in the treatment and dewatering, which is cumbersome to operate, unfriendly to equipment, not conducive to industrialization, and has a high production cost.

[0006] For example, a Chinese invention patent, publication number CN115850158A, discloses a method for preparing nicardipine hydrochloride, and its synthetic route is as follows:

[0007]

[0008] The disadvantage of this preparation method is that the content of nicardipine hydrochloride is difficult to control and can only be 96-98%, which cannot meet the requirements of the pharmacopoeia, and expensive EDCI chemical reagent is used.

[0009] The preparation method of nicardipine hydrochloride reported in the document Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities, Chemical and Pharmaceutical Bulletin; 1986.34(4).1589-1606 has the following synthesis route:

[0010]

[0011] This preparation method uses anhydrous magnesium sulfate for drying during the post-processing process, which is cumbersome to operate and not conducive to industrialization. In addition, the benzene residue is far higher than the PDE value, and the content is difficult to meet the requirements of the pharmacopoeia. Summary of the invention

[0012] The present invention aims to solve at least one of the technical problems existing in the above-mentioned prior art. To this end, the present invention provides a method for preparing nicardipine hydrochloride. The content of nicardipine hydrochloride prepared by the preparation method is 99.9-101.0%, which meets the requirements of the pharmacopoeia, and no benzene solvent is detected, and no potential genotoxic impurities are contained.

[0013] To solve the above technical problems, the first aspect of the present invention provides a method for preparing nicardipine hydrochloride, the method comprising the step of refining a crude product of nicardipine hydrochloride, wherein the mixed solvent used for the refining comprises acetone, tetrahydrofuran and acetonitrile.

[0014] The study found that the nicardipine hydrochloride obtained by refining with a specific mixed solvent including acetone, tetrahydrofuran and acetonitrile can effectively increase the content of nicardipine hydrochloride in the product.

[0015] Preferably, the volume ratio of acetone, tetrahydrofuran and acetonitrile is 2:1:0.2.

[0016] As a further improvement of the above scheme, the raw material for preparing nicardipine hydrochloride includes 2-naphthalenesulfonyl chloride.

[0017] The study found that the reaction activity of 2-naphthalenesulfonyl chloride is higher than that of traditional toluenesulfonic acid chloride, the intermediate obtained is easy to purify, and it does not introduce hydroxychlorinated impurities with potential genotoxicity, which are difficult to control.

[0018] The chemical structure of the potential genotoxic impurity is as follows:

[0019]

[0020] Meanwhile, the present invention uses 2-naphthalenesulfonyl chloride instead of traditional methylsulfonyl chloride and p-methylbenzenesulfonyl chloride, which can avoid using expensive condensing agents such as EDCI for condensation in the preparation process, not only reducing the production cost, but also eliminating the need to use anhydrous magnesium sulfate for drying in the post-treatment, simplifying the preparation process, and the prepared nicardipine hydrochloride has a high content, and no benzene solvent is detected, which meets the requirements of the pharmacopoeia.

[0021] As a further improvement of the above scheme, the preparation method of nicardipine hydrochloride comprises the following steps:

[0022] (1) Compound 1, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid monomethyl ester and chemical 2,2-chloroethanol are used as starting materials, heated, and reacted in a first inert solvent to obtain compound 3;

[0023] (2) Compound 3 and compound 4, 2-naphthalenesulfonyl chloride are mixed and subjected to esterification reaction in a second inert solvent to obtain compound 5;

[0024] (3) Compound 5 and Compound 6 are mixed, heated, and subjected to substitution reaction; hydrochloric acid is then added to form a salt to obtain Compound 7, i.e., crude nicardipine hydrochloride;

[0025] (4) adding a mixed solvent to compound 7 for purification, dissolving it, cooling it for crystallization, and obtaining compound 8, i.e., nicardipine hydrochloride;

[0026] The synthetic route of the nicardipine hydrochloride is as follows:

[0027]

[0028] Specifically, the present invention uses 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid monomethyl ester (compound 1) and 2-chloroethanol (compound 2) as starting materials to obtain compound 3; then reacts with 2-naphthalenesulfonyl chloride (compound 4) for esterification to obtain compound 5; then reacts with N-methylbenzylamine (compound 6) for substitution, and forms a salt with hydrochloric acid to obtain a crude nicardipine hydrochloride product (compound 7); finally, it is refined in a mixed solvent to obtain a finished product of nicardipine hydrochloride (compound 8).

[0029] Preferably, in step (1), the mass ratio of compound 1 to compound 2 is 3:(2-3).

[0030] Preferably, in step (1), the heating temperature is 35-60°C; further preferably, the heating temperature is 40-60°C.

[0031] Preferably, in step (1), the first inert solvent comprises acetone.

[0032] Preferably, in step (1), the reaction step of compound 3 is: firstly, compound 1 is mixed with a first inert solvent, refluxed and stirred, and then compound 2 is slowly added dropwise thereto, and after the addition is completed, the reaction is carried out for 4-6 hours, and the reaction is controlled by TLC until the end.

[0033] Preferably, in step (2), the mass ratio of compound 3 to compound 4 is 1:(1-3).

[0034] Preferably, in step (2), the temperature of the esterification reaction is -5°C to 35°C.

[0035] Preferably, in step (2), the second inert solvent comprises acetonitrile.

[0036] Preferably, in step (2), the reaction step of compound 5 is: first, compound 3 is mixed with a second inert solvent, and stirred at 30±5°C to obtain a solution of compound 3; another compound 4 is mixed with a second inert solvent, and stirred to dissolve to obtain a solution of compound 4; then the solution of chemical 3 is slowly added dropwise to the solution of compound 4 at 0±5°C, and the reaction is carried out for 4-6 hours after the addition is completed, and the reaction is controlled by TLC until the end.

[0037] Preferably, in step (3), the heating temperature is 65-85° C.; more preferably, the heating temperature is 70-85° C. In step (3), compound 6 is used as the solvent, and no additional solvent is required.

[0038] Preferably, in step (3), the hydrochloric acid is dilute hydrochloric acid; further preferably, the concentration of the hydrochloric acid is 1-5 mol / L; further preferably, the concentration of the hydrochloric acid is 1-2 mol / L.

[0039] Preferably, in step (3), the reaction step of compound 7 is: firstly, compound 5 and compound 6 are mixed, the temperature is raised to 65-85°C, and the reaction is carried out for 10-15 hours, and no obvious material is observed by TLC during the reaction; then the temperature is lowered to 0±5°C, dilute hydrochloric acid is added to wash the layers, and the organic layer is retained; and dilute hydrochloric acid is continued to be added to stir to form salt.

[0040] Preferably, in step (4), the temperature is lowered to 0-10°C.

[0041] Preferably, in step (4), the purification step of compound 8 is: adding a mixed solvent to compound 7, heating to 40±5°C to dissolve; then cooling to 0-10°C, stirring and crystallizing for 2-4 hours to obtain compound 8.

[0042] Preferably, step (1), step (2), step (3) and step (4) are all carried out under the protection of an inert gas.

[0043] Preferably, the inert gas is nitrogen.

[0044] Compared with the prior art, the above technical solution of the present invention has at least the following technical effects or advantages:

[0045] The present invention adopts a specific mixed solvent of acetone, tetrahydrofuran and acetonitrile in the refining process of the crude nicardipine hydrochloride, thereby effectively increasing the content of nicardipine hydrochloride in the product. At the same time, the present invention uses 2-naphthalenesulfonyl chloride instead of traditional methylsulfonyl chloride and p-methylbenzenesulfonyl chloride to prepare nicardipine hydrochloride, thereby further increasing the content of nicardipine hydrochloride in the product, avoiding the use of expensive condensing agents such as EDCI in the preparation process, thereby reducing the production cost; and there is no need to use anhydrous magnesium sulfate for drying, thereby simplifying the preparation process and facilitating industrial production.

[0046] The content of nicardipine hydrochloride prepared by the invention is 99.98-100.10%, benzene solvent is not detected, and potential genotoxic impurities are not contained, thus meeting the requirements of pharmacopoeia. BRIEF DESCRIPTION OF THE DRAWINGS

[0047] Figure 1 is the HPLC chromatogram of nicardipine hydrochloride prepared in Example 1;

[0048] Figure 2 is the mass spectrum of nicardipine hydrochloride prepared in Example 1;

[0049] Figure 3 This is the NMR image of nicardipine hydrochloride prepared in Example 1;

[0050] Figure 4 is the HPLC chromatogram of nicardipine hydrochloride prepared in Example 2;

[0051] Figure 5 is the HPLC chromatogram of nicardipine hydrochloride prepared in Example 3;

[0052] Figure 6 is the mass spectrum of the potential genotoxic impurities in Comparative Example 3;

[0053] Figure 7 This is the NMR image of the potential genotoxic impurities in Comparative Example 3. DETAILED DESCRIPTION

[0054] The present invention is described in detail below in conjunction with the examples, so that the technical personnel of the relevant technical field can understand the present invention. It is necessary to point out here that the examples are only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. The non-essential improvements and adjustments made to the present invention by the skilled person in the relevant field according to the above invention content should still belong to the scope of protection of the present invention. At the same time, the raw materials mentioned below that are not described in detail are all commercially available products; the process steps or preparation methods that are not mentioned in detail are all process steps or preparation methods known to those skilled in the art.

[0055] The preparation process of 1.2 mol / L dilute hydrochloric acid in the following examples and comparative examples is as follows: 100 mL of 12 mol / L concentrated hydrochloric acid is measured, 900 mL of water is added, and the mixture is stirred and diluted at 30±5° C. to obtain the product.

[0056] Example 1

[0057] A method for preparing nicardipine hydrochloride comprises the following steps:

[0058] (1) Synthesis of compound 3, the synthetic route is as follows:

[0059]

[0060] In a 500mL three-necked flask, 30.00g of compound 1, 14.97g of sodium hydroxide and 150mL of acetone were added, nitrogen protection, reflux stirring (internal temperature 56°C), and 20.89g of 2-chloroethanol was slowly added dropwise; the reaction was continued for 5 hours after the addition, and the reaction was controlled to be complete by TLC, and the temperature was restored to normal; 300mL of ethyl acetate (EA) was added, and water was added for extraction and washing twice, with 300mL of water used each time; the organic layer was retained and concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); vortexed until no obvious droplets appeared to obtain a brown viscous liquid; 30mL of isopropanol was added and stirred to disperse; 60mL of n-heptane was slowly added dropwise at 30±5°C; stirring was maintained for 1 hour after the addition was completed; the temperature was lowered to -10±5°C and stirred for 1 hour; suction filtered to obtain a yellow solid compound 3 weighing 27.12g and a molar yield of 79.82%.

[0061] (2) Synthesis of compound 5, the synthetic route is as follows:

[0062]

[0063] In a 250mL three-necked flask, add 18.00g of compound 3, 33.88g of sodium hydroxide, and 45mL of acetonitrile, under nitrogen protection, stir at 30±5℃; take another 38.24g of 2-naphthalenesulfonyl chloride, add 45mL of acetonitrile, stir to dissolve, transfer to a dropping funnel for later use; slowly drop 20.0g of 2-naphthalenesulfonyl chloride in acetonitrile; react at room temperature for 5 hours after the addition; control the reaction by TLC; stop heating after the reaction is completed, cool to 50±5°C; add all the above 5% sodium carbonate aqueous solution and stir for 0.5 hour; transfer the reaction solution to a dropping funnel, slowly add 20mL of glacial acetic acid; after the addition, add 200mL of ethyl acetate to extract and stratify, retain the organic layer, and wash with 200mL of water; retain the organic layer and concentrate under reduced pressure (50±5°C, ≤-0.09Mpa); vortex until no droplets appear, add 36mL of methanol to dissolve; slowly add 144mL of n-heptane at 0±5°C; crystallize for 2 hours after the addition; filter to obtain a yellow solid, dry at 30±5°C to obtain compound 4, with a weight of 23.03g and a yield of 84.99%, and the content of potential genotoxic impurities is not detected.

[0064] (3) Synthesis of compound 8, nicardipine hydrochloride, the synthetic route is as follows:

[0065]

[0066] In a 500mL three-necked flask, 15.00g of compound 5 and 84.40g of compound 6 were added, nitrogen protection was applied, and the temperature was raised to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 250mL of 1.2mol / L dilute hydrochloric acid was added to wash and layer, the organic layer was retained, and 250mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the salt was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; 100mL of acetone, 50mL of tetrahydrofuran, and 10mL of acetonitrile were added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8, which weighed 13.21g, had a yield of 96.70%, and no benzene residue was detected.

[0067] The material cost of preparing nicardipine hydrochloride in Example 1 is 2327 yuan / kg, and the total yield of nicardipine hydrochloride is 65.60%.

[0068] Figure 1-3 The HPLC, mass spectrum and NMR of nicardipine hydrochloride prepared in Example 1 are respectively Figure 2 The molecular ion peak [MH] can be found in - =478. Since the substance is a hydrochloride salt, its free state is shown in the mass spectrum, proving that its free molecular weight is 479. Figure 3 The characterization results of NMR are as follows:

[0069]

[0070] 1 H NMR(600MHz,DMSO-d6)δ10.36(s,1H),9.24(s,1H),8.03-7.90(m,2H),7.63-7.42(m,7H),4.99(s,1 H),4.48-4.13(m,4H),3.64-3.49(m,3H),2.62(d,J=5.1Hz,4H),2.31(d,J=2.1Hz,3H),2.28(s,3H).

[0071] Example 2

[0072] A method for preparing nicardipine hydrochloride comprises the following steps:

[0073] (1) Synthesis of compound 3, the synthetic route is as follows:

[0074]

[0075] In a 500mL three-necked flask, 300.0g of compound 1, 149.7g of sodium hydroxide and 150mL of acetone were added, nitrogen protection, reflux stirring, and 208.9g of 2-chloroethanol was slowly added dropwise; the reaction was completed for 5 hours, and the reaction was controlled by TLC until the end, and the temperature was restored to room temperature; EA3000mL was added, and water was added for extraction and washing twice, with a water dosage of 3000mL each time; the organic layer was retained and concentrated under reduced pressure (50±5℃, ≤-0.09Mpa); vortexed until no obvious droplets appeared to obtain a brown viscous liquid; 300mL of isopropanol was added and stirred and dispersed; 600mL of n-heptane was slowly added dropwise at 30±5℃; stirring was maintained for 1 hour after the dropwise completion; the temperature was lowered to -10±5℃ and stirred for 1 hour; suction filtered to obtain a yellow solid compound 3 weighing 275.2g and a molar yield of 81.00%.

[0076] (2) Synthesis of compound 5, the synthetic route is as follows:

[0077]

[0078] In a 250mL three-necked flask, add 180.0g of compound 3, 338.8g of sodium hydroxide, and 450mL of acetonitrile, under nitrogen protection, stir at 30±5℃; take another 382.4g of 2-naphthalenesulfonyl chloride, add 450mL of acetonitrile, stir to dissolve, transfer to a dropping funnel for later use; slowly drop 200.0g of 2-naphthalenesulfonyl chloride in acetonitrile; react at room temperature for 5 hours after the addition; control the reaction by TLC; stop heating after the reaction is completed, cool to 50±5°C; add all the above 5% sodium carbonate aqueous solution and stir for 0.5 hour; transfer the reaction solution to a dropping funnel, slowly add 200mL of glacial acetic acid; after the addition, add 2000mL of ethyl acetate for extraction and stratification, retain the organic layer, and wash with 2000mL of water; retain the organic layer and concentrate under reduced pressure (50±5°C, ≤-0.09Mpa); vortex until no droplets appear, add 360mL of methanol to dissolve; slowly add 1440mL of n-heptane at 0±5°C; crystallize for 2 hours after the addition; filter to obtain a yellow solid, dry at 30±5°C to obtain compound 4, with a weight of 240.3g and a yield of 88.68%, and no potential genotoxic impurities are detected.

[0079] (3) Synthesis of compound 8, nicardipine hydrochloride, the synthetic route is as follows:

[0080]

[0081] In a 500mL three-necked flask, 150.0g of compound 5 and 844.0g of compound 6 were added, nitrogen protection was applied, and the temperature was raised to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 2500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, the organic layer was retained, and 2500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; 1000mL of acetone, 500mL of tetrahydrofuran, and 100mL of acetonitrile were added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8, which weighed 132.1g and had a yield of 96.70%. No benzene residue was detected, and its liquid chromatogram was as shown below Figure 4 shown.

[0082] The material cost of preparing nicardipine hydrochloride in Example 2 is 2216 yuan / kg, and the total yield of nicardipine hydrochloride is 69.46%.

[0083] Example 3

[0084] A method for preparing nicardipine hydrochloride comprises the following steps:

[0085] (1) Synthesis of compound 3, the synthetic route is as follows:

[0086]

[0087] In a 500mL three-necked flask, 300.0g of compound 1, 149.7g of sodium hydroxide and 150mL of acetone were added, nitrogen protection was applied, stirring was performed at 40°C, and 300.0g of 2-chloroethanol was slowly added dropwise; the reaction was continued for 5 hours after the addition, and the reaction was controlled to be complete by TLC, and the temperature was restored to normal; 3000mL of EA was added, and water was added for extraction and washing twice, with 3000mL of water used each time; the organic layer was retained and concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); vortexed until no obvious droplets appeared to obtain a brown viscous liquid; 300mL of isopropanol was added and stirred and dispersed; 600mL of n-heptane was slowly added dropwise at 30±5°C; stirring was maintained for 1 hour after the addition was completed; the temperature was lowered to -10±5°C and stirred for 1 hour; suction filtered to obtain a yellow solid compound 3 weighing 270.2g and a molar yield of 79.53%.

[0088] (2) Synthesis of compound 5, the synthetic route is as follows:

[0089]

[0090] In a 250mL three-necked flask, add 180.0g of compound 3, 338.8g of sodium hydroxide, and 450mL of acetonitrile, under nitrogen protection, stir at 30±5℃; take another 180.0g of 2-naphthalenesulfonyl chloride, add 450mL of acetonitrile, stir to dissolve, transfer to a dropping funnel for later use; slowly drop 200.0g of 2-naphthalenesulfonyl chloride in acetonitrile; react at 0±5°C for 5 hours after dropping; control the reaction by TLC; stop heating after the reaction is over, cool to 50±5°C; add all the above 5% sodium carbonate aqueous solution and stir for 0.5 hour; transfer the reaction solution to a dropping funnel, slowly drop 200mL of glacial acetic acid; after dropping, add 2000mL of ethyl acetate for extraction and stratification, retain the organic layer, and wash with 2000mL of water; retain the organic layer, and concentrate under reduced pressure (50±5°C, ≤-0.09Mpa); vortex until no droplets appear, add 360mL of methanol to dissolve; slowly drop 1440mL of n-heptane at 0±5°C; crystallize for 2 hours after dropping; filter to obtain a yellow solid, dry at 30±5°C to obtain compound 4, with a weight of 238.3g, a yield of 87.95%, and no potential genotoxic impurities were detected.

[0091] (3) Synthesis of compound 8, nicardipine hydrochloride, the synthetic route is as follows:

[0092]

[0093] In a 500mL three-necked flask, 150.0g of compound 5 and 844.0g of compound 6 were added, nitrogen protection was applied, and the temperature was raised to 70°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 2500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, the organic layer was retained, and 2500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; 1000mL of acetone, 500mL of tetrahydrofuran, and 100mL of acetonitrile were added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to 0°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8, which weighed 135.1g and had a yield of 98.89%. No benzene residue was detected, and its HPLC chromatogram was as shown below Figure 5 shown.

[0094] The material cost of preparing nicardipine hydrochloride in Example 3 is 2207 yuan / kg, and the total yield of nicardipine hydrochloride is 69.17%.

[0095] Comparative Example 1

[0096] Nicardipine hydrochloride was prepared according to the preparation method disclosed in Example 1 of the Chinese invention patent (publication number CN115850158A), comprising the following steps:

[0097] Add 4.65 g of dichloromethane to a 100 mL single-mouth bottle, start stirring, and then add 1.00 g of intermediate M3, 0.588 g of DMAP (4-dimethylaminopyridine), 0.865 kg of EDCI (carbodiimide hydrochloride) and 0.746 g of SM4, heat to 45 ° C for reaction, react for about 6 hours and then control by TLC. After the reaction is complete, add the prepared 5% sodium carbonate aqueous solution and 4.65g dichloromethane, stir for 20±5min, let stand, separate the liquids, wash the organic phase with 5.00g water once, collect the organic layer, and cool to 5 ° C, add the prepared 6N hydrochloric acid dropwise, keep warm and stir for 1 hour, let stand, separate the liquids, wash the organic phase with 5.00g water once, collect the organic layer, and concentrate the organic phase to dryness under reduced pressure at 40 ° C to obtain a foamy solid. Add 7.90g acetone and 0.79g methanol to the residue, heat to reflux, dissolve and then cool to 25 ° C for crystallization for 15 hours, then cool to 5 ° C, stir for 4 hours, filter, rinse with 0.79g acetone, and dry under reduced pressure at 50±5 ° C to obtain light yellow nicardipine hydrochloride.

[0098] Comparative Example 2

[0099] Nicardipine hydrochloride is prepared according to the preparation method disclosed in the document (Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities, Chemical and Pharmaceutical Bulletin), comprising the following steps:

[0100] Add 6.0g of compound 16b and 20mL of nitrogen methylbenzylamine to a 100mL single-mouth bottle, react at 95℃ for 8 hours to stop the reaction, cool down, add 10mL of dichloromethane to dissolve, wash twice with 10mL of 2N dilute hydrochloric acid solution, wash once with 10mL of water, dry and dehydrate with 5g of anhydrous magnesium sulfate for 30min, filter and concentrate the filtrate to obtain a sample, add 10mL of ethyl acetate to crystallize at low temperature of 5℃ overnight, filter to obtain a crude product, and crystallize through acetone to obtain the finished product of compound 17, nicardipine hydrochloride, with a melting point of 168-170℃ and 0.06% benzene residue. Drying with anhydrous magnesium sulfate was not thorough, and the glass wall was severely impacted during the stirring process, and the amplification process had a greater impact on the equipment.

[0101] Comparative Example 3

[0102] The only difference between Comparative Example 3 and Example 1 is that in step (3) of Comparative Example 3, the volume ratio of acetone, tetrahydrofuran and acetonitrile is 2:1:1 / 30.

[0103] In Comparative Example 3, the synthesis steps of Compound 8 Nicardipine Hydrochloride are as follows:

[0104] In a 500mL three-necked flask, 30.00g of compound 5 and 168.81g of compound 6 were added, and the mixture was protected by nitrogen and heated to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, the organic layer was retained, and 500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; a mixed solvent of 300mL of acetone, 150mL of tetrahydrofuran, and 10mL of acetonitrile was added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8 with a yield of 78.5%.

[0105] Comparative Example 3 During the preparation process, potential genotoxic impurities were detected with a content of 5.6%. The mass spectrum and NMR images of the impurities are as follows: Figure 6-7 As shown. Figure 6 The molecular ion peak [MH] can be found in - =393, proving its molecular weight is 394. Figure 7 The characterization results of NMR are as follows:

[0106] 1 H NMR (600MHz, DMSO-d6) δ9.13(s,1H),8.11-7.90(m,2H),7.64(d,J=7.8Hz,1H),7.54(t,J=7.9Hz,1H),4.99(s,1 H),4.22(qdd,J=12.3,6.3,3.9Hz,2H),3.78(qdd,J=11.8,6.4,3.9Hz,2H),3.55(s,3H),2.30(d,J=7.2Hz,6H).

[0107] Comparative Example 4

[0108] The only difference between Comparative Example 4 and Comparative Example 3 is that in step (3) of Comparative Example 4, the volume ratio of acetone, tetrahydrofuran and acetonitrile is 4:1:1 / 80.

[0109] In Comparative Example 4, the synthesis steps of Compound 8 Nicardipine Hydrochloride are as follows:

[0110] In a 500mL three-necked flask, 30.00g of compound 5 and 168.81g of compound 6 were added, and the mixture was protected by nitrogen and heated to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, the organic layer was retained, and 500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; a mixed solvent of 400mL of acetone, 100mL of tetrahydrofuran, and 5mL of acetonitrile was added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8 with a yield of 78.5%.

[0111] Comparative Example 5

[0112] The only difference between Comparative Example 5 and Comparative Example 3 is that in step (3) of Comparative Example 5, acetonitrile is not added, and the volume ratio of acetone to tetrahydrofuran is 4:1.

[0113] In Comparative Example 5, the synthesis steps of Compound 8, nicardipine hydrochloride, are as follows:

[0114] In a 500mL three-necked flask, 30.00g of compound 5 and 168.81g of compound 6 were added, and the mixture was protected by nitrogen and heated to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, the organic layer was retained, and 500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; a mixed solvent of 400mL of acetone and 100mL of tetrahydrofuran was added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8 with a yield of 70.5%.

[0115] Comparative Example 6

[0116] The only difference between Comparative Example 6 and Comparative Example 3 is that in step (3) of Comparative Example 6, acetone is not added, and the volume ratio of tetrahydrofuran to acetonitrile is 10:1.

[0117] In Comparative Example 6, the synthesis steps of Compound 8, nicardipine hydrochloride, are as follows:

[0118] In a 500mL three-necked flask, 30.00g of compound 5 and 168.81g of compound 6 were added, and the mixture was protected by nitrogen and heated to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, the organic layer was retained, and 500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; a mixed solvent of 1000mL of tetrahydrofuran and 100mL of acetonitrile was added, and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8 with a yield of 68.5%.

[0119] Comparative Example 7

[0120] The only difference between Comparative Example 7 and Comparative Example 3 is that in step (3) of Comparative Example 7, acetone and tetrahydrofuran are not added, and only acetonitrile is added.

[0121] In Comparative Example 7, the synthesis steps of Compound 8, Nicardipine Hydrochloride, are as follows:

[0122] In a 500mL three-necked flask, 30.00g of compound 5 and 168.81g of compound 6 were added, and the mixture was protected by nitrogen and heated to 85°C for reaction; the reaction was carried out for 12.5 hours; no obvious raw material was observed by TLC during the reaction; after the reaction was completed, the temperature was lowered to 0±5°C, 500mL of 1.2mol / L dilute hydrochloric acid was added to wash and separate the layers, and the organic layer was retained. 500mL of 1.2mol / L dilute hydrochloric acid was added at 0±5°C and stirred for 0.5 hours to form a salt; the layers were separated, the organic layer was retained, and the mixture was concentrated under reduced pressure (50±5°C, ≤-0.09Mpa); the mixture was vortexed until a yellow viscous solid appeared to obtain compound 7; 400mL of acetonitrile was added and the mixture was heated to 40±5°C to dissolve; the temperature was lowered to -10°C and stirred for crystallization for 3 hours to obtain the finished product nicardipine hydrochloride compound 8 with a yield of 71.3%.

[0123] Performance Testing

[0124] 1. Related substances testing methods

[0125] The liquid chromatography conditions were as follows:

[0126] Chromatographic column: Use octadecyl bonded silica gel as filler (Waters XTERRARP184.6×150mm, 3.5μm or chromatographic column with equivalent performance);

[0127] Mobile phase A: acetonitrile: methanol = 82:18 (V / V);

[0128] Mobile phase B: phosphate buffer (3.4 g / L potassium dihydrogen phosphate aqueous solution, pH adjusted to 4.8 with 0.1 mol / L potassium hydroxide aqueous solution);

[0129] Flow rate: 1.0ml / min;

[0130] Detection wavelength: 237nm;

[0131] Injection volume: 50 μl;

[0132] Column temperature: 35°C;

[0133] The gradient elution program is shown in 1.

[0134] Table 1:

[0135] Time (minutes) Mobile phase A (%) Mobile phase B (%) 0 20 80 5 20 80 40 60 40 45 60 40 50 20 80 60 20 80

[0136] 2. Content test method

[0137] (1) Instrument: Electronic analytical balance, moisture-potential integrated titrator

[0138] (2) Reagents: acetic anhydride, glacial acetic acid, perchloric acid titration solution

[0139] (3) Solution preparation:

[0140] 1) Diluent (blank solution): Take 700 ml of acetic anhydride and 300 ml of glacial acetic acid and mix them evenly.

[0141] 2) Test solution: Take about 0.9 g of nicardipine hydrochloride, weigh accurately, place in a 250 ml beaker, add 100 ml of diluent, and dissolve by ultrasonication.

[0142] (4) Determination method

[0143] Titrate with 0.1mol / L perchloric acid (potentiometric titration), and the equivalence point is determined by consuming 25ml of titrant or 5 equivalence points. Titrate the blank solution first, then the test solution. Each milliliter of 0.1mol / L perchloric acid is equivalent to 51.60mg of nicardipine hydrochloride.

[0144] (5) Calculation formula

[0145]

[0146] Where: cactual: actual concentration of titrant, mol / L;

[0147] cTheoretical: Theoretical concentration of the titrant, 0.1 mol / L;

[0148] △V: The difference between the volume of the titrant consumed by the sample when it reaches the equivalence point and the volume of the blank solution consumed, mL;

[0149] 51.6: Every 1ml of titration solution (0.1mol / L) consumed is equivalent to 51.6mg of nicardipine hydrochloride, mg

[0150] M: sample weight of the test product, g

[0151] D: Drying loss of sample, %

[0152] (6) Acceptable standards

[0153] EP Pharmacopoeia requirements:

[0154] Content: Calculated on a dry basis, contains nicardipine hydrochloride (C 26 H 29 N3O6·HCl) is between 99.0% and 101.0%.

[0155] The present invention adopts the above test method to detect the related substances (purity) and content of nicardipine hydrochloride prepared in each embodiment and comparative example, and the results are shown in Table 2.

[0156] Table 2:

[0157]

[0158]

[0159] As shown in Table 2, the content of nicardipine hydrochloride prepared in Examples 1-3 of the present invention is 99.98-100.10%, which can meet the requirements of the pharmacopoeia. However, in Comparative Examples 1-2 and Comparative Examples 3-7, the content of nicardipine hydrochloride prepared is low and does not meet the requirements of the pharmacopoeia because the existing preparation method of nicardipine hydrochloride or other mixed solvents different from those in the examples (acetone, tetrahydrofuran and acetonitrile in a volume ratio of 2:1:0.2) are used in the refining process.

[0160] For ordinary technicians in the technical field to which the present invention belongs, several simple deductions or substitutions can be made without departing from the concept of the present invention, without having to go through creative labor. Therefore, simple improvements made to the present invention by those skilled in the art based on the disclosure of the present invention should be within the protection scope of the present invention. The above embodiments are preferred embodiments of the present invention, and all processes similar to the present invention and equivalent changes made should belong to the protection scope of the present invention.

Claims

1. A method for preparing nicardipine hydrochloride, characterized in that: The preparation method comprises the step of refining a crude product of nicardipine hydrochloride, wherein the mixed solvent used in the refining comprises acetone, tetrahydrofuran and acetonitrile.

2. The method for preparing nicardipine hydrochloride according to claim 1, characterized in that: The volume ratio of the acetone, tetrahydrofuran and acetonitrile is 2:1:0.

2.

3. The method for preparing nicardipine hydrochloride according to claim 1, characterized in that: The raw materials for preparing nicardipine hydrochloride include 2-naphthalenesulfonyl chloride.

4. The method for preparing nicardipine hydrochloride according to any one of claims 1 to 3, characterized in that: The following steps are involved: (1) Compound 1, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylic acid monomethyl ester and chemical 2,2-chloroethanol are used as starting materials, heated, and reacted in a first inert solvent to obtain compound 3; (2) Compound 3 and compound 4, 2-naphthalenesulfonyl chloride are mixed and subjected to esterification reaction in a second inert solvent to obtain compound 5; (3) Compound 5 and Compound 6 are mixed, heated, and subjected to substitution reaction; hydrochloric acid is then added to form a salt to obtain Compound 7, i.e., crude nicardipine hydrochloride; (4) adding a mixed solvent to compound 7 for purification, dissolving it, cooling it for crystallization, and obtaining compound 8, i.e., nicardipine hydrochloride; The synthetic route of the nicardipine hydrochloride is as follows:

5. The method for preparing nicardipine hydrochloride according to claim 4, characterized in that: In step (1), the mass ratio of compound 1 to compound 2 is 3:(2-3).

6. The method for preparing nicardipine hydrochloride according to claim 4, characterized in that: In step (1), the heating temperature is 35-60° C.; and / or the first inert solvent comprises acetone.

7. The method for preparing nicardipine hydrochloride according to claim 4, characterized in that: In step (2), the mass ratio of compound 3 to compound 4 is 1:(1-3).

8. The method for preparing nicardipine hydrochloride according to claim 4, characterized in that: In step (2), the temperature of the esterification reaction is -5°C to 35°C; and / or the second inert solvent comprises acetonitrile.

9. The method for preparing nicardipine hydrochloride according to claim 4, characterized in that: In step (3), the heating temperature is 65-85°C; and / or, in step (4), the temperature is lowered to 0-10°C.

10. The method for preparing nicardipine hydrochloride according to claim 4, characterized in that: Step (1), step (2), step (3) and step (4) are all carried out under the protection of inert gas.

Citation Information

Patent Citations

  • Preparation method of high-purity dipine drug key intermediate M2

    CN115850158A

  • 1,4-Dihydropyridine derivative and pharmaceutical composition containing same

    EP0063365A1

  • Dihydropyridine derivative and its production

    JP1986093160A

  • Preparation of thiocycloalkno [3,2-b] pyridines

    US4879384A